Targeted Action and Financing the Fight Against Antimicrobial Resistance in Asia 2025

Solutions to antimicrobial resistance across the AMR value chain FIGURE 10 Spotting the next bug Data from monitoring and surveillance efforts, such as epidemiological (i.e. disease outbreak) data or disease evolution (e.g. bacteria morphology and phenotyping) can help to expedite biomarker discovery through sequencing and genome-based prediction. Better diagnostics More affordable and more accurate diagnostics can contribute to better data collection and monitoring of antimicrobial usage.Closing the feedback loop Monitoring and surveillance is needed to measure actual antimicrobial usage and assess the effectiveness of stewardship and education.Monitoring and surveillanceBiomarker discoveryDevelopment of drugs, diagnostics, vaccines (including clinical trials)Product go-to-market including regulatory approval, manufacturing)Access and distribution of product Antimicrobial stewardship and end-user education Antimicrobial usageMonitoring and surveillanceData collection and analysis Disease prevention and improved WASH Sprint: Prevent2 Sprint: Monitor3 Marathon: Treat4 Sprint: Educate1 Source: Centre for Impact Investing and Practices (CIIP). 36 Targeted Action and Financing the Fight Against Antimicrobial Resistance in Asia